Viewing Study NCT05920135


Ignite Creation Date: 2025-12-24 @ 10:22 PM
Ignite Modification Date: 2026-01-04 @ 12:47 AM
Study NCT ID: NCT05920135
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-04-27
First Post: 2023-05-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: First-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment With EGFR TKI
Sponsor: Bridge Biotherapeutics, Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module